Using data that feeds into the Country Sustainability Ranking (CSR), which analyses the environmental, social and governance (ESG) characteristics of 150 nations, the report shows how unprepared many countries were when the crisis reached a global scale in March.
The biannual CSR scores countries based on a wide range of metrics, including access to health care and the quality of governance, both of which have come to the fore in how countries have imposed lockdowns to stop the spread of the virus.
“The coronavirus has shaken the foundations of many countries with devastating effect,” says Max Schieler, author of the special report, ‘Covid-19 and ESG data: spotting the cracks before the quake.’ “But many of the structural weaknesses that have exacerbated the crisis, were already visibly evident in country ESG performance data.”
“A closer look reveals striking parallels between ESG scores and effective crisis management. Surprisingly, high scores on health system metrics proved insufficient in predicting a country’s coping capacity – proving that there are no magic indicators with full predictive power. Data must be analyzed collectively and comprehensively for patterns to surface and true root causes identified.”
“Reflective of this, strong governance and institutional indicators were strongly correlated with a country’s coping capacity, helping explain the surprising success and failure of many countries in dealing with the crisis.”
“But strong governance should not be confused with absolute governance; authoritarian regimes have fared no better than Western democracies in combatting and controlling the coronavirus’ spread and impact,” he says.
The highest death tolls in the world have been in the US, Italy and Spain and the lowest in Japan, South Korea and Singapore. China, where the outbreak began in Wuhan in February, eventually managed to gain control of the situation after imposing strict lockdowns and quarantines, a practice that was later copied around the world.
The report provides an early indication of which countries have managed the crisis more successfully. Israel, Germany and South Korea have turned out to be the safest countries in which to contract Covid-19, while Italy, the US and the UK were the least safe. Italy was the first country to exceed China in terms of deaths before the US took on that grim record, exceeding 50,000 fatalities by 28 April.
The poor showing of the US, which as a wealthy democracy with a modern health care system would ordinarily have a high ESG ranking, should not come as a surprise, says Schieler.
“Unlike other countries, the Trump administration not only failed to take early action but also hampered efforts by maintaining a stance of denial and disregard for scientific evidence and dismissing the early warnings of health officials and other experts,” he says.
“President Trump’s recurrent attacks on both domestic and international institutions since his takeover of power is already reflected in declining US scores across several governance indicators.”
The CSR is primarily used by investors to look for sustainability risks that may not be reflected in a country’s debt rating or credit default swaps, making it invaluable for deciding whether to buy government bonds. It also provides top-down analysis for investment decisions regarding the equities or bonds of companies operating in each country.
“For investors, the implications are clear – if ESG data can provide insights on a global pandemic, it can also be a powerful tool for understanding and mitigating geopolitical and country risks within an investment portfolio,” says Schieler.
“And as recent events this year (and last) have emphatically underscored, societal and geopolitical risks can be sweeping and destructive for countries, companies, and portfolios alike.”
“It has taken a crisis of epic proportions to expose to the world to what was already partially visible in country ESG data. We must hope the magnitude and sharpness of the initial shock and subsequent aftershocks will leave us deeply wounded but acutely sensitized to early warnings that can help avert future risks – worthy advice for citizen, countries, and investors.”
The Robeco Capital Growth Funds have not been registered under the United States Investment Company Act of 1940, as amended, nor or the United States Securities Act of 1933, as amended. None of the shares may be offered or sold, directly or indirectly in the United States or to any U.S. Person (within the meaning of Regulation S promulgated under the Securities Act of 1933, as amended (the “Securities Act”)). Furthermore, Robeco Institutional Asset Management B.V. (Robeco) does not provide investment advisory services, or hold itself out as providing investment advisory services, in the United States or to any U.S. Person (within the meaning of Regulation S promulgated under the Securities Act).
This website is intended for use only by non-U.S. Persons outside of the United States (within the meaning of Regulation S promulgated under the Securities Act who are professional investors, or professional fiduciaries representing such non-U.S. Person investors. By clicking “I Agree” on our website disclaimer and accessing the information on this website, including any subdomain thereof, you are certifying and agreeing to the following: (i) you have read, understood and agree to this disclaimer, (ii) you have informed yourself of any applicable legal restrictions and represent that by accessing the information contained on this website, you are not in violation of, and will not be causing Robeco or any of its affiliated entities or issuers to violate, any applicable laws and, as a result, you are legally authorized to access such information on behalf of yourself and any underlying investment advisory client, (iii) you understand and acknowledge that certain information presented herein relates to securities that have not been registered under the Securities Act, and may be offered or sold only outside the United States and only to, or for the account or benefit of, non-U.S. Persons (within the meaning of Regulation S under the Securities Act), (iv) you are, or are a discretionary investment adviser representing, a non-U.S. Person (within the meaning of Regulation S under the Securities Act) located outside of the United States and (v) you are, or are a discretionary investment adviser representing, a professional non-retail investor. Access to this website has been limited so that it shall not constitute directed selling efforts (as defined in Regulation S under the Securities Act) in the United States and so that it shall not be deemed to constitute Robeco holding itself out generally to the public in the U.S. as an investment adviser. Nothing contained herein constitutes an offer to sell securities or solicitation of an offer to purchase any securities in any jurisdiction. We reserve the right to deny access to any visitor, including, but not limited to, those visitors with IP addresses residing in the United States.
This website has been carefully prepared by Robeco. The information contained in this publication is based upon sources of information believed to be reliable. Robeco is not answerable for the accuracy or completeness of the facts, opinions, expectations and results referred to therein. Whilst every care has been taken in the preparation of this website, we do not accept any responsibility for damage of any kind resulting from incorrect or incomplete information. This website is subject to change without notice. The value of the investments may fluctuate. Past performance is no guarantee of future results. If the currency in which the past performance is displayed differs from the currency of the country in which you reside, then you should be aware that due to exchange rate fluctuations the performance shown may increase or decrease if converted into your local currency. For investment professional use only. Not for use by the general public.